The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety
Abstract
This section reviews the history, pharmacology, administration, efficacy, and toxicity of intravenous iron. Intravenous iron offers advantages over oral iron for the treatment of iron deficiency anemia across a wide range of disease states associated with absolute and functional iron deficiency. However, there remain concerns about the acute safety profiles of the available preparations and the potential for long-term toxicity with their repeated administration. Seven intravenous iron formulations are available. Confusion concerning the relative toxicities of the different formulations abounds. The similarities and differences are discussed. Iron repletion has been associated with adverse outcomes in infections. The relationship, if any, between intravenous iron administration and infections is reviewed. The potential advantages of total dose infusion (TDI), complete repletion in a single setting, are highlighted. A new paradigm for iron replacement therapy in iron deficiency anemia is presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Lüscher, T. F., Bart, B., Banasiak, W., Niegowska, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908355 · Cited by 2,083
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
Eschbach, J. W., Egrie, J. C., Downing, M. R., Browne, J. K., & Adamson, J. W. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701083160203 · Cited by 2,005
Iron, anaemia, and inflammatory bowel diseases
Gasche, C., Lomer, M. C. E., Cavill, I., & Weiss, G. (2004) · Gut · doi:10.1136/gut.2003.035758 · Cited by 494
Update on adverse drug events associated with parenteral iron
Chertow, G. M., Mason, P. D., Vaage-Nilsen, O., & Ahlmén, J. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi253 · Cited by 457
The adverse effect of iron repletion on the course of certain infections.
Murray, M. J., Murray, A. B., Murray, M. B., & Murray, C. J. (1978) · BMJ · doi:10.1136/bmj.2.6145.1113 · Cited by 453
Auerbach, M., Ballard, H., Trout, J. R., McIlwain, M., Ackerman, A., Bahrain, H., Balan, S., Barker, L., & Rana, J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.119 · Cited by 414
Self-citationCoyne, D. W., Kapoian, T., Suki, W., Singh, A. K., Moran, J. E., Dahl, N. V., & Rizkala, A. R. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006091034 · Cited by 391
Fishbane, S., Frei, G. L., & Maesaka, J. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90151-5 · Cited by 377
Kulnigg, S., Stoinov, S., Simanenkov, V., Dudar, L. V., Karnafel, W., Garcia, L. C., Sambuelli, A. M., D'Haens, G., & Gasche, C. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01744.x · Cited by 349
Time-Dependent Associations between Iron and Mortality in Hemodialysis Patients
Kalantar-Zadeh, K., Regidor, D. L., McAllister, C. J., Michael, B., & Warnock, D. G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040423 · Cited by 285
Intravenous Iron Dextran in Clinical Medicine
Hamstra, R. D. (1980) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1980.03300430028018 · Cited by 280
Iron and infection: the heart of the matter
Bullen, J. J., Rogers, H. J., Spalding, P. B., & Ward, C. G. (2005) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.11.010 · Cited by 273
The safety of intravenous iron dextran in hemodialysis patients
Fishbane, S., Ungureanu, V.-D., Maesaka, J. K., Kaupke, C. J., Lim, V., & Wish, J. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90463-1 · Cited by 272
Henry, D. H., Dahl, N. V., Auerbach, M., Tchekmedyian, S., & Laufman, L. R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-2-231 · Cited by 264
Self-citationOxidative stress and renal injury with intravenous iron in patients with chronic kidney disease
Agarwal, R., Vasavada, N., Sachs, N. G., & Chase, S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00648.x · Cited by 261
Buchman, A. L. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01280.x · Cited by 253
Van Wyck, D. B., Roppolo, M., Martinez, C. O., Mazey, R. M., & Mcmurray, S. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00758.x · Cited by 226
Van Wyck, D. B., Mangione, A., Morrison, J., Hadley, P. E., Jehle, J. A., & Goodnough, L. T. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02327.x · Cited by 211
Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextrans
Faich, G., & Strobos, J. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70183-6 · Cited by 208
Structure, chemistry, and pharmacokinetics of intravenous iron agents.
Danielson, B. G. (2004) · PubMed · doi:10.1097/01.asn.0000143814.49713.c5 · Cited by 208
Michael, B., Coyne, D. W., Fishbane, S., Folkert, V., Lynn, R., Nissenson, A. R., Agarwal, R., Eschbach, J. W., Fadem, S. Z., Trout, J. R., et al. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00314.x · Cited by 199
Intravenous iron sucrose: Establishing a safe dose
Chandler, G., Harchowal, J., & Macdougall, I. C. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.28587 · Cited by 198
Anemia and inflammatory bowel diseases
Gomollón, F., & Gisbert, J. P. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4659 · Cited by 194
Clinical update: intravenous iron for anaemia
Auerbach, M., Ballard, H., & Glaspy, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60689-8 · Cited by 193
Self-citationAdministration of Parenteral Iron and Mortality among Hemodialysis Patients
Feldman, H. I., Joffe, M., Robinson, B., Knauss, J., Cizman, B., Guo, W., Franklin-Becker, E., & Faich, G. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000128009.69594.be · Cited by 192
Ferumoxytol as an Intravenous Iron Replacement Therapy in Hemodialysis Patients
Provenzano, R., Schiller, B., Rao, M., Coyne, D., Brenner, L., & Pereira, B. J. G. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02840608 · Cited by 187
Ferric Gluconate Reduces Epoetin Requirements in Hemodialysis Patients with Elevated Ferritin
Kapoian, T., O'Mara, N. B., Singh, A. K., Moran, J., Rizkala, A. R., Geronemus, R., Kopelman, R. C., Dahl, N. V., & Coyne, D. W. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050606 · Cited by 181
Silverberg, D. S., Iaina, A., Peer, G., Kaplan, E., Levi, B. A., Frank, N., Steinbruch, S., & Blum, M. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90546-6 · Cited by 173
Gasche, C., Dejaco, C., Waldhoer, T., Tillinger, W., Reinisch, W., Fueger, G. F., Gangl, A., & Lochs, H. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-10-199705150-00006 · Cited by 158
On the relative safety of parenteral iron formulations
Chertow, G. M., Mason, P. D., Vaage-Nilsen, O., & Ahlmén, J. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh185 · Cited by 149
Safety of Ferumoxytol in Patients With Anemia and CKD
Singh, A. K., Patel, T. V., Hertel, J., Bernardo, M. V., Kausz, A., & Brenner, L. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.08.001 · Cited by 147
Gotloib, L., Silverberg, D. S., Fudin, R., & Shostak, A. (2006) · Journal of Nephrology · doi:10.1093/joneph/19.2.161 · Cited by 136
Suspected iron dextran-related adverse drug events in hemodialysis patients
Fletes, R., Lazarus, J. M., Gage, J. O., & Chertow, G. M. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80123-2 · Cited by 135
QUANTITATIVE ASPECTS OF IRON DEFICIENCY IN HYPOCHROMIC ANEMIA
Heath, C. W., Strauss, M. B., & Castle, W. B. (1932) · Journal of Clinical Investigation · doi:10.1172/jci100478 · Cited by 119
Múñoz, M., Breymann, C., García‐Erce, J. A., Gómez‐Ramírez, S., Colet, J. C., & Bisbe, E. (2007) · Vox Sanguinis · doi:10.1111/j.1423-0410.2007.01014.x · Cited by 118
Intravenous iron: From anathema to standard of care
Auerbach, M., Coyne, D., & Ballard, H. S. (2008) · American Journal of Hematology · doi:10.1002/ajh.21154 · Cited by 115
Self-citationIron sucrose in hemodialysis patients: Safety of replacement and maintenance regimens
Aronoff, G. R., Bennett, W. M., Blumenthal, S. S., Charytan, C., Pennell, J. P., Reed, J., Rothstein, M., Strom, J. A., Wolfe, A., Wyck, D. V., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00872.x · Cited by 104
The role of intravenous iron in anemia management and transfusion avoidance
Auerbach, M., Goodnough, L. T., Picard, D., & Maniatis, A. G. (2008) · Transfusion · doi:10.1111/j.1537-2995.2007.01633.x · Cited by 103
Self-citationBarton, J. C., Barton, E. H., Bertoli, L. F., Gothard, C. H., & Sherrer, J. S. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00396-x · Cited by 103
Coyne, D. W., Adkinson, F., Nissenson, A. R., Fishbane, S. N., Agarwal, R., Eschbach, J. W., Michael, B., Folkert, V. W., BATLLE, D. C., Trout, J. R., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00703.x · Cited by 98
Mamula, P., Piccoli, D. A., Peck, S. N., Markowitz, J. E., & Baldassano, R. N. (2002) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200203000-00011 · Cited by 89
Hoen, B., Paul-Dauphin, A., & Kessler, M. (2002) · Clinical Nephrology · doi:10.5414/cnp57457 · Cited by 77
Erythropoietin for End-Stage Renal Disease
Adamson, J. W., & Eschbach, J. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390910 · Cited by 77
INTRAMUSCULAR IRON THERAPY IN IRON-DEFICIENCY ANÆMIA
Baird, I. M., & Podmore, D. A. (1954) · The Lancet · doi:10.1016/s0140-6736(54)92555-6 · Cited by 75
Sav, T., Tokgöz, B., Sipahioğlu, M. H., Deveci, M., Sarı, İ., Oymak, O., & Utaş, C. (2007) · Renal Failure · doi:10.1080/08860220701278208 · Cited by 71
Covic, A. C., & Mircescu, G. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq069 · Cited by 71
Intravenous iron dextran for severe refractory restless legs syndrome
Ondo, W. G. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2009.12.002 · Cited by 68
Macdougall, I. C., & Roche, A. J. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.04.032 · Cited by 68
Intravenous iron in inflammatory bowel disease
Múñoz, M., Gómez‐Ramírez, S., & García‐Erce, J. A. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4666 · Cited by 68
Critchley, J., & Dundar, Y. (2007) · Transfusion Alternatives in Transfusion Medicine · doi:10.1111/j.1778-428x.2007.00042.x · Cited by 67
Auerbach, M., Chaudhry, M. A., Goldman, H., et al. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90098-1 · Cited by 64
Self-citationMONIEM, K. A., & Bhandari, S. (2007) · Transfusion Alternatives in Transfusion Medicine · doi:10.1111/j.1778-428x.2007.00050.x · Cited by 61
Non–Transferrin-Bound Iron in the Serum of Hemodialysis Patients Who Receive Ferric Saccharate
Scheiber‐Mojdehkar, B., Lutzky, B., Schaufler, R., Sturm, B., & Goldenberg, H. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000130149.18412.56 · Cited by 60
Varde, K. N. (1964) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1964.tb04380.x · Cited by 59
High-Molecular Weight Iron Dextran: A Wolf in Sheep's Clothing?
Rodgers, G. M., Auerbach, M., Cella, D., Chertow, G. M., Coyne, D. W., Glaspy, J. A., & Henry, D. H. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008030255 · Cited by 56
Self-citationMcCarthy, J. T., Regnier, C. E., Loebertmann, C. L., & Bergstralh, E. J. (2000) · American Journal of Nephrology · doi:10.1159/000046199 · Cited by 56
Walters, B. A. J., & Wyck, D. B. V. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh811 · Cited by 51
Safety of Iron Sucrose in Hemodialysis Patients Intolerant to Other Parenteral Iron Products
Charytan, C., Schwenk, M. H., Al-Saloum, M. M., et al. (2004) · Nephron Clinical Practice · doi:10.1159/000076401 · Cited by 46
Intravenous Iron and the Risk of Infection in End‐Stage Renal Disease Patients
Perazella, M. A., Brewster, U. C., & Perazella, M. A. (2004) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2004.17115.x · Cited by 35
Safety and efficacy of sodium ferric gluconate complex in patients with chronic kidney disease
Panesar, A., & Agarwal, R. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.36322 · Cited by 27
Maintaining iron balance with total-dose infusion of intravenous iron dextran.
Case, G. (1998) · PubMed · Cited by 19
Gilreath, J. A., Sageser, D. S., Jorgenson, J. A., et al. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.0044 · Cited by 16
Comparative therapeutic study of T.D.I. and I.M. injections of iron dextran complex in anaemia.
Kanakaraddi, V. P., Hoskatti, C. G., Nadig, V. S., Patil, C., & Maiya, M. (1973) · PubMed · Cited by 11
Cited by
Camaschella, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1401038 · Cited by 1,678
Camaschella, C. (2019) · Blood · doi:10.1182/blood-2018-05-815944 · Cited by 702
The Safety of Intravenous Iron Preparations
Avni, T., Bieber, A., Grossman, A., Green, H., Leibovici, L., & Gafter-Gvili, A. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.10.007 · Cited by 441
Koskenkorva-Frank, T. S., Weiss, G., Koppenol, W. H., & Burckhardt, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.09.001 · Cited by 406
Choi, Y. H., & Han, H.-K. (2018) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0370-4 · Cited by 406
Metadata
- Authors
- Auerbach, M., & Ballard, H.
- Venue
- Hematology
- Publisher
- American Society of Hematology
- Published
- 2010-12-04
- Volume
- 2010
- Issue
- 1
- Pages
- 338-347
- ISSN
- 1520-4383 (ISSN-L)
- 1520-4391
- OpenAlex
- W2123020477
- Cited by
- 310
- References
- 63
- FWCI
- 10.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.